Maxair

Active Ingredient(s): Pirbuterol
FDA Approved: * December 30, 1986
Pharm Company: * 3M
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Maxair Overview

Pirbuterol (trade name Maxair) is a short-acting β2 adrenoreceptor agonist with bronchodilating action used in the treatment of asthma, available (as pirbuterol acetate) as a breath-activated metered-dose inhaler (Maxair Autohaler). Contents 1 Clinical use 2 Mode of action 3 Pharmacokinetics 4 Adverse effects 5 References 6 External links Clinical use Pirbuterol is used in asthma for reversal of acute bronchospasm, and also as a maintenance medication to prevent future attacks. ...

Read more Maxair Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pirbuterol

Recent Maxair Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pirbuterol
  • Aerosol, Metered: 0.2mg/actuation, 0.2mg/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pirbuterol or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA